Clinical Trials

The PHocus Study is a Global Phase 2 clinical trial evaluating the safety and efficacy of an investigational drug, mosliciguat, in adults with pulmonary hypertension (PH) associated with interstitial lung disease (ILD).

To find out more, visit https://phocusstudy.com or contact clinicaltrials@pulmovant.com.